By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
ICCNICCNICCN
  • Home
  • Conferences
  • Events
  • Media
  • Publications
  • Resources
    • NCCN
    • ASCO
    • Hematology
Sign In
ICCNICCN
  • Home
  • Conferences
  • Events
  • Media
  • Publications
  • Resources
Search
  • Home
  • Conferences
  • Events
  • Media
  • Publications
  • Resources
    • NCCN
    • ASCO
    • Hematology

Trending →

T-DXd Plus Pertuzumab Receives FDA Approval, Shifting the Frontline HER2-Positive Paradigm

By MedOnc2
December 15, 2025

FDA Approves Niraparib Plus Abiraterone Acetate and Prednisone for BRCA2-Mutated mCSPC

By MedOnc2
December 15, 2025

FDA Approves Durvalumab for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma

By MedOnc2
December 15, 2025

FDA Grants Traditional Approval to Pirtobrutinib (Jaypirca®) for CLL/SLL

By MedOnc2
December 15, 2025

Enfortumab Vedotin + Pembrolizumab for Muscle-Invasive Bladder Cancer (MIBC)

By MedOnc2
November 22, 2025
Login Sign In
Follow US
© ICCN All Rights Reserved.

Events

Potential new drug for Pancreatic Cancer
New Drug

Potential new drug for Pancreatic Cancer

By MedOnc2
August 10, 2025
2 Min Read

→ Latest Events

Potential new drug for Pancreatic Cancer
EventsMediaUncategorized

Potential new drug for Pancreatic Cancer

August 10, 2025
Interactive Cancer Care Network

Powered By Designjoom-Empowering Brands since 2010